Last reviewed · How we verify

NCT04653636: IRCAP

MRI and Clinical Predictive Factors of the Response to Arthrographic Distension in Severe Capsulitis

Completed Last updated 12 September 2025
What this trial tests

trial testing Arthrographic distension in Adhesive Capsulitis in 55 participants. Completed in 14 November 2022.

Timeline
9 October 2020
Primary endpoint
21 October 2022
14 November 2022

Quick facts

Lead sponsorAssistance Publique - Hôpitaux de Paris
StatusCompleted
Study typeOBSERVATIONAL
Enrollment55
Start date9 October 2020
Primary completion21 October 2022
Estimated completion14 November 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with Adhesive Capsulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to identify clinical and MRI factors associated to a better response to arthrographic distension in patients with severe capsulitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Adhesive Capsulitis

Currently open trials in the same condition.

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04653636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing